PharmVar GeneFocus: CYP2C19

The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. Th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical pharmacology and therapeutics 2021-02, Vol.109 (2), p.352-366
Hauptverfasser: Botton, Mariana R., Whirl‐Carrillo, Michelle, Del Tredici, Andria L., Sangkuhl, Katrin, Cavallari, Larisa H., Agúndez, José A. G., Duconge, Jorge, Lee, Ming Ta Michael, Woodahl, Erica L., Claudio‐Campos, Karla, Daly, Ann K., Klein, Teri E., Pratt, Victoria M., Scott, Stuart A., Gaedigk, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C19 gene. CYP2C19 genetic variation impacts the metabolism of many drugs and has been associated with both efficacy and safety issues for several commonly prescribed medications. This GeneFocus provides a comprehensive overview and summary of CYP2C19 and describes how haplotype information catalogued by PharmVar is utilized by the Pharmacogenomics Knowledgebase and the Clinical Pharmacogenetics Implementation Consortium (CPIC).
ISSN:0009-9236
1532-6535
1532-6535
DOI:10.1002/cpt.1973